MiddleGround Capital to shop valve manufacturer Vytl Controls, sources say The target generated $75m of EBITDA based on $500m in revenue over the last year, PE Hub understands.

Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will no longer pursue an approval in the U.S., following recent stu | It’s ...

PARIS, France—More than one in five Acurate neo2 transcatheter heart valves (Boston Scientific) implanted in patients as part of the ACURATE investigational device exemption (IDE) study were ...

Consequently, through conducting our own FinFET transistor measurements, we calibrate cryogenic transistor models at 10K. With the 7nm cryogenic transistor data, we model Cryo-CACTI for cryogenic ...

The cryogenic valve assembly market is projected to grow from USD 4.83 billion in 2024 to USD 7.21 billion by 2029 at a CAGR of 8.3%.

The global Cryogenic Valve Assembly Market is anticipated to grow from estimated USD 4.83 billion in 2024 to USD 7.21 billion by 2029, at a CAGR of 8.3% during the forecast period. This market is ...

The Cryogenic Valves Market report, unveiled by Future Market Insights—an ESOMAR Certified Market Research and Consulting Firm—presents invaluable insights and meticulous analysis of the Cryogenic ...

Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence t ...

LOS ANGELES, CA—In patients ages 60 years or younger undergoing surgical aortic valve replacement, mechanical valves are associated with a survival benefit compared with bioprosthetic valves, ...